#Path2Cures Proceeds to Pennsylvania TOMORROW

#Path2Cures Proceeds to Pennsylvania TOMORROW

The following press release was published by the House Committee on Energy and Commerce on Aug. 28, 2014. It is reproduced in full below.

The Energy and Commerce Committee’s 21st Century Cures initiative will take center stage Friday, Aug. 29, in Lancaster, Pennsylvania, as Health Subcommittee Chairman Joe Pitts (R-PA) will host a roundtable. Pitts has assembled an all-star lineup of health care professionals and innovators to contribute to the cures effort including Dr. Francis Collins, Director of the National Institutes of Health, and Dr. Margaret Hamburg, Commissioner of the U.S. Food and Drug Administration. Energy and Commerce Chairman Fred Upton (R-MI), Health Subcommittee Vice Chairman Michael C. Burgess, M.D. (R-TX), and Health Subcommittee Ranking Member Frank Pallone (D-NJ) will also participate.

“On Friday, the top health leaders in Pennsylvania and the nation’s capital will come together in Lancaster for an important dialogue on how we can accelerate the pace of cures," said Pitts. “This is a top priority for the Energy and Commerce Committee, and the Health Subcommittee is the tip of the spear in this effort. Our work and conversations continue to boost treatments and cures, spur research and development, and keep the globe’s top innovators and job creators here in the United States. There is no more important initiative that touches more lives than 21st Century Cures."

Friday’s event will begin at 1:30 p.m. at the Lancaster Farm and Home Center. More details are available online here. C-SPAN is scheduled to record the event and broadcast at a later date to be determined.

Participants and attendees will include:

Dr. Francis S. Collins

Director

National Institutes of Health

Dr. Margaret A. Hamburg

Commissioner

U.S. Food and Drug Administration

Dr. Louis A. Marotti, Jr.

Chief of Neurosurgery

Lancaster Regional Medical Center

Brain Orthopedic Spine Specialists, P.C.

The Honorable James C. Greenwood

President and CEO

Biotechnology Industry Organization

Dr. Norman W. Barton

Vice President

Global Clinical Development Team Leader

Shire

Dr. Lon Cardon

Senior Vice President

Alternative Discovery and Development

GlaxoSmithKline

Dr. William A. Hanlon

Vice President, Head of Global Regulatory Affairs

Covance, Inc.

Mr. Clint Matthews

President and CEO

Reading Health System

Dr. Chi Van Dang

Director, Abramson Cancer Center

University of Pennsylvania

Mr. Caroll H. Neubauer

Chairman and CEO

B. Braun Medical, Inc.

Dr. Joseph W. St. Geme, III

Physician-in-Chief

The Children’s Hospital of Philadelphia

Jennifer Westdyke

Parent of Hydrocephalus Child

Pediatric Hydrocephalus Foundation, Inc.

Read more on the 21st Century Cures initiative here, and join the conversation on Facebook and Twitter using #Path2Cures.

Source: House Committee on Energy and Commerce